polyp

FDA approves Dupixent (dupilumab) as treatment for chronic rhinosinusitis

Chronic rhinosinusitis (CRS) is a clinical condition characterized by prolonged inflammation (more than 12 weeks) of the nose and paranasal sinuses. Signs and symptoms of sinusitis include headache, swelling of face, facial pain, nasal discharge, dizziness, and breathing difficulties. Sinusitis is caused by allergies, bacterial and viral infections and presence of nasal polyps (growths on